SecurityAMD / Advanced Micro Devices, Inc. (007903107)
President & CEOSu Lisa T
Form 4 Count420
Form 8-K Count94
Form 10-Q Count19
Form 3 Count15

SEC Filings - 10K, 8K, Annual Reports

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Advanced Micro Devices, Inc.


DateFormTitle
2018-05-08 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-05-03 10-Q AMD / Advanced Micro Devices, Inc. 10-Q (Quarterly Report)
2018-04-25 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-03-19 DEFA14A AMD / Advanced Micro Devices, Inc. DEFA14A
2018-03-19 DEF 14A AMD / Advanced Micro Devices, Inc. DEF 14A
2018-03-06 PRE 14A AMD / Advanced Micro Devices, Inc. PRE 14A
2018-03-05 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-02-27 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-02-27 10-K AMD / Advanced Micro Devices, Inc. 10-K (Annual Report)
2018-02-12 8-K AMD / Advanced Micro Devices, Inc. 8-K NEO 2017 EIP (Current Report)
2018-02-08 SC 13G/A AMD / Advanced Micro Devices, Inc. / BlackRock Inc. - 3G/A (Passive Investment)
2018-02-08 SC 13G/A AMD / Advanced Micro Devices, Inc. / BlackRock Inc. - 3G/A (Passive Investment)
2018-01-30 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-01-10 SC 13G/A AMD / Advanced Micro Devices, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)
2018-01-10 SC 13G/A AMD / Advanced Micro Devices, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)
2017-11-02 10-Q Advanced Micro Devices 10-Q (Quarterly Report)
2017-11-01 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-10-24 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-08-07 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-08-18 144 Advanced Micro Devices FORM 144
2017-08-04 SC 13D/A Advanced Micro Devices AMENDMENT NO. 9 TO SCHEDULE 13D (Activist Acquisition of More Than 5% of Shares)
2017-08-18 144 Advanced Micro Devices FORM 144
2017-08-04 SC 13D/A Advanced Micro Devices AMENDMENT NO. 9 TO SCHEDULE 13D (Activist Acquisition of More Than 5% of Shares)
2017-08-03 10-Q Advanced Micro Devices 10-Q (Quarterly Report)
2017-07-25 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-07-05 SC 13D/A Advanced Micro Devices AMENDMENT NO. 8 TO SCHEDULE 13D (Activist Acquisition of More Than 5% of Shares)
2017-07-05 SC 13D/A Advanced Micro Devices AMENDMENT NO. 8 TO SCHEDULE 13D (Activist Acquisition of More Than 5% of Shares)
2017-07-03 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-05-30 SD Advanced Micro Devices SD
2017-05-08 S-8 Advanced Micro Devices S-8
2017-05-08 10-Q Advanced Micro Devices 10-Q (Quarterly Report)
2017-05-01 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-04-28 8-K Advanced Micro Devices FORM 8-K (Current Report/Significant Event)
2017-03-22 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-03-13 8-K/A Advanced Micro Devices 8-K/A (Current Report/Significant Event)
2017-03-08 DEFA14A Advanced Micro Devices DEFA14A
2017-03-08 DEF 14A Advanced Micro Devices DEF 14A
2017-03-06 SC 13D/A Advanced Micro Devices AMENDMENT NO. 7 (Activist Acquisition of More Than 5% of Shares)
2017-03-06 SC 13D/A Advanced Micro Devices AMENDMENT NO. 7 (Activist Acquisition of More Than 5% of Shares)
2017-03-03 144 Advanced Micro Devices FORM 144
2017-03-02 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-02-21 10-K Advanced Micro Devices 10-K (Annual Report)
2017-02-21 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-02-21 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-02-09 SC 13G/A Advanced Micro Devices 3G/A (Passive Acquisition of More Than 5% of Shares)
2017-02-09 SC 13G/A Advanced Micro Devices 3G/A (Passive Acquisition of More Than 5% of Shares)
2017-01-31 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-01-19 SC 13G/A Advanced Micro Devices 3G/A (Passive Acquisition of More Than 5% of Shares)
2017-01-19 SC 13G/A Advanced Micro Devices 3G/A (Passive Acquisition of More Than 5% of Shares)
2016-12-22 S-3ASR Advanced Micro Devices S-3ASR
AMD: Advanced Micro Devices Stock Analysis and Research Report

2017-09-28 - Asif

We are a global semiconductor company with facilities around the world. Within the global semiconductor industry, we offer primarily: x86 microprocessors, as standalone devices or as incorporated as an accelerated processing unit (APU), chipsets, discrete graphics processing units (GPUs) and professional graphics processors; and server and embedded processors, semi-custom System-on-Chip (SoC) products and technology for game consoles. We also license portions of our intellectual property portfolio. In this section, we will describe the general financial condition and the results of operations of Advanced Micro Devices, Inc. and its wholly-owned subsidiaries (collectively, “us,” “our” or “AMD”), including a discussion of our results of operations for the quarter and six months ended July 1, 2017 compared to the quarter and six months ended June 25, 2016 , an analysis of changes in our financial condition and a discussion of our contractual obligations. We believe our fin...

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 007903107